Repros Therapeutics (RPRX) Reports Q2 Loss of $0.18/Share
Repros Therapeutics (NASDAQ: RPRX) reported Q2 EPS of ($0.18), versus ($0.32) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Repros Therapeutics (NASDAQ: RPRX) reported Q2 EPS of ($0.18), versus ($0.32) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.